Market Overview

What It Means For CVS To Be Removed From Tricare Network In December

Share:

Baird lowered its 2017 earnings per share estimate for CVS Health Corp (NYSE: CVS), blaming the action on last Friday's news that CVS will be taken off the Tricare Network in December.

Elaborating on Friday's news, analyst Eric Coldwell noted that Tricare of the government Department of Defense conveyed its intention to add Walgreens Boots Alliance Inc (NASDAQ: WBA) to its national retail pharmacy network and remove CVS from it. The analyst estimates the share of CVS in the approximately 130 million Tricare total scripts to be 25 percent.

Consequently, Baird removed $2.25 billion of revenues from its estimates for CVS, starting December 1, with most of the loss in traditional retail. The EPS impact estimated using the average operating margin is less than 2 percent.

The firm noted that the company sees neutralized brand inflation across platforms. However, the firm sees downside pricing risk following EpiPen and distributor comments. Accordingly, the firm lowered its estimates.

Despite the estimate reduction, Baird maintained its Outperform rating, citing a trio of factors, namely valuation, quality platform and a strong track record. However, the price target was lowered to $104 from $111.

At time of writing, shares of CVS Health were down 1.15 percent at $87.87.

Latest Ratings for CVS

DateFirmActionFromTo
Sep 2020Piper SandlerInitiates Coverage OnOverweight
Aug 2020Credit SuisseMaintainsOutperform
Aug 2020SVB LeerinkMaintainsMarket Perform

View More Analyst Ratings for CVS
View the Latest Analyst Ratings

 

Related Articles (CVS + WBA)

View Comments and Join the Discussion!

Posted-In: BairdAnalyst Color Price Target Analyst Ratings

Latest Ratings

StockFirmActionPT
MSFTStifelMaintains245.0
TXRHJP MorganMaintains67.0
SBUXJP MorganMaintains82.0
MCDJP MorganMaintains220.0
CMGJP MorganMaintains1,115.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com